Remote monitoring of IBD

Comparison of patient reported disease activity scores combined with fecal calprotectin home tests for remote monitoring of IBD patients: a cross-sectional cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21966

Enrollment

286

Registered

2021-03-08

Start date

2021-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Established diagnosis of CD or UC according to ECCO guidelines - Scheduled for an ileocolonoscopy at the endoscopy ward of the MUMC+ (regardless of indication) - Aged 18 years or older - Smartphone with internet access (for use of QOC home test)

Exclusion criteria

Exclusion criteria: - Unclassified IBD - Ileostomy, colostomy, ileoanal pouch anastomosis or ileorectal anastomosis - Insufficient knowledge of Dutch language

Design outcomes

Primary

Measure	Time frame
The main study endpoint is the diagnostic test accuracy of the below listed remote monitoring tools, using ileocolonoscopy as reference: - MIAH questionnaire with QOC test - Mobile health Index with QOC test - Manitoba IBD index with QOC test - IBD-control with QOC test - QOC test (without questionnaire)	—

Secondary

Measure	Time frame
- Agreement between fecal calprotectin levels measured by QOC tests and by routine MUMC+ laboratory tests - Association between the questions used in the various patient based disease activity scores and endoscopic disease activity	—

Contacts

Public ContactLaura Janssen

Maastricht University

laura.janssen@maastrichtuniversity.nl0433884190

Outcome results